Orthobiologics in Orthopaedics, Part Deux (with special guest Asheesh Bedi‪)‬ OrthoJOE

In this episode, Marc and Mo are joined by special guest and world-renowned sports-medicine expert Asheesh Bedi (Director of the Michigan Center for Human Athletic Medicine and Performance, Harold W. and Helen L. Gehring Professor of Orthopaedic Surgery, Chief of Sports Medicine and Shoulder Surgery at the University of Michigan, head orthopaedic surgeon for University of Michigan athletics, and consultant for numerous NBA, NFL, and NHL teams) in a continuation of their previous discussion of orthobiologics, one of the most rapidly evolving areas of orthopaedics. What are the “major players” in this field, and are we there yet? Do PRP and stem cells play a role in the management of patients in 2021? What progress has been made, and what challenges and opportunities remain?
OrthoJOE Mailbag: feedback, comments, and suggestions from our audience can be sent to orthojoe@jbjs.org
Links:

Reider B. Proceed With Caution. The American Journal of Sports Medicine. 2009;37(11):2099-2101. doi:10.1177/0363546509352786. https://journals.sagepub.com/doi/full/10.1177/0363546509352786
Bauer, Thomas W. MD, PhD Stem Cell Therapy for Knee Pain—What Exactly Are We Injecting, and Why?, The Journal of Bone and Joint Surgery: September 21, 2016 - Volume 98 - Issue 18 - p 1509-1510 doi: 10.2106/JBJS.16.00872. https://jbjs.org/reader.php?id=203068&rsuite_id=1261189&native=1&source=The_Journal_of_Bone_and_Joint_Surgery/98/18/1509/fulltext&topics=bs#info